The Octopus Value Investing logo
The Octopus Value Investing
Subscribe
  • The Octopus Value Investing
  • Topics
  • Miscellaneous

Miscellaneous

Section with content covering different topics to what I usually do

News & Trending TopicsTheon InternationalPandoraThe Octopus toolboxLonza Group AGIntroductionMiscellaneousThe Octopus PortfolioColoplast A/SSectors in briefInvestment pillsSchott Pharma AGJeronimo MartinsEarnings ReviewNovo Nordisk
MiscellaneousMiscellaneous
+1+1
#2 Investment Sidebar Snapshots
Jul 13, 2025

#2 Investment Sidebar Snapshots

Compiling One Month of Novo Nordisk News & Updates

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
#1 Investment Sidebar Snapshots
Jun 01, 2025

#1 Investment Sidebar Snapshots

Samsung Biologics, GLP-1 Incentives and Alphabet

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
+1+1
What Does It Mean for a Drug to Be Regulatory Approved?
Dec 10, 2024

What Does It Mean for a Drug to Be Regulatory Approved?

The Differential Quality of Regulatory Approved Drugs

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
Hims&Hers Health: My Take
Nov 24, 2024

Hims&Hers Health: My Take

My Rationale to Drop Hims&Hers Health Investment Case

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
+1+1
Understanding NASH/MASH
Sep 08, 2024

Understanding NASH/MASH

Uncovering the potential behind Novo Nordisk's optionality

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
The Danish Watchlist
Apr 01, 2024

The Danish Watchlist

List of Danish quality companies I follow

The Octopus Value Investing
The Octopus Value Investing

The Octopus Value Investing

Home

Posts

Authors

© 2025 The Octopus Value Investing.

Privacy policy

Terms of use

Powered by beehiiv